Settlement of Litigation. No settlement, consent judgment or other final disposition of an action for infringement or validity of patent claims that relate in any material way to Compounds or the use of Dapoxetine in the Lilly Field, whether composition or method claims, may be entered into as to any Licensed Patent without Lilly’s prior written consent, which consent shall not be unreasonably withheld.
Appears in 3 contracts
Sources: Termination and License Agreement, Termination and License Agreement (Furiex Pharmaceuticals, Inc.), Termination and License Agreement (Pharmaceutical Product Development Inc)